Product How it works Pricing Blog FAQ About Contact
Wave Life Sciences

Wave Life Sciences (NASDAQ: WVE) revenue

Wave Life Sciences reported revenue of $42.7m for fiscal 2025, 60.5% less than in fiscal 2024 ($108.3m). Since fiscal 2016 its revenue has grown by 3,812.7%, an average growth of 50.3% a year.

Wave Life Sciences's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2022, −91.1%.

Revenue, in millions of US dollars1.120163.9201714.4201816.0201920.1202041.020213.62022113.32023108.3202442.72025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$42.7m−60.5%−$215.4m−504.1%
2024$108.3m−4.4%−$110.4m−101.9%
2023$113.3m+3,005.1%−$68.0m−60.0%
2022$3.6m−91.1%−$162.7m−4,459.3%
2021$41.0m+104.0%−$127.0m−310.1%
2020$20.1m+25.6%−$153.4m−763.9%
2019$16.0m+10.9%−$208.3m−1,303.4%
2018$14.4m+270.3%−$159.5m−1,106.7%
2017$3.9m+256.5%−$102.4m−2,630.1%
2016$1.1m—−$55.7m−5,102.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Wave Life Sciences revenue compared with its sector

By revenue for its latest fiscal year, Wave Life Sciences ranks 334th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Wave Life Sciences, −60.5%.

RankCompanyRevenueRevenue growth
332ndFennec Pharmaceuticals$44.6m−6.1%
333rdAquestive Therapeutics$44.5m−22.6%
334thWave Life Sciences$42.7m−60.5%
335thCoherus Oncology$42.2m59.8%
336thKoru Medical Systems$41.1m22.2%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Wave Life Sciences

How much revenue did Wave Life Sciences make in fiscal 2025?
Wave Life Sciences reported revenue of $42.7m for fiscal 2025, compared with $108.3m in fiscal 2024.
How much has the revenue of Wave Life Sciences grown?
Between fiscal 2016 and fiscal 2025 it went from $1.1m to $42.7m: 3,812.7% more, an average growth of 50.3% a year.
What was the best year for revenue at Wave Life Sciences?
Of its last 10 fiscal years, fiscal 2023, with $113.3m.
Where does Wave Life Sciences rank in its sector by revenue?
It ranks 334th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Wave Life Sciences come from?
From the annual report (Form 10-K) that Wave Life Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Wave Life Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Wave Life Sciences: the Wave Life Sciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.